88 related articles for article (PubMed ID: 18301137)
1. Role of apoptosis in pressure-overload cardiomyopathy.
Anselmi A; Gaudino M; Baldi A; Vetrovec GW; Bussani R; Possati G; Abbate A
J Cardiovasc Med (Hagerstown); 2008 Mar; 9(3):227-32. PubMed ID: 18301137
[TBL] [Abstract][Full Text] [Related]
2. Pressure overload.
Frohlich ED; Susic D
Heart Fail Clin; 2012 Jan; 8(1):21-32. PubMed ID: 22108724
[TBL] [Abstract][Full Text] [Related]
3. Volume overload.
Carabello BA
Heart Fail Clin; 2012 Jan; 8(1):33-42. PubMed ID: 22108725
[TBL] [Abstract][Full Text] [Related]
4. Effects of left ventricular volume overload on mitochondrial and death-receptor-mediated apoptotic pathways in the transition to heart failure.
Moorjani N; Westaby S; Narula J; Catarino PA; Brittin R; Kemp TJ; Narula N; Sugden PH
Am J Cardiol; 2009 May; 103(9):1261-8. PubMed ID: 19406269
[TBL] [Abstract][Full Text] [Related]
5. Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy.
Maron MS; Appelbaum E; Harrigan CJ; Buros J; Gibson CM; Hanna C; Lesser JR; Udelson JE; Manning WJ; Maron BJ
Circ Heart Fail; 2008 Sep; 1(3):184-91. PubMed ID: 19808288
[TBL] [Abstract][Full Text] [Related]
6. Concentric versus eccentric remodeling.
Carabello BA
J Card Fail; 2002 Dec; 8(6 Suppl):S258-63. PubMed ID: 12555129
[TBL] [Abstract][Full Text] [Related]
7. Hypertension and heart failure: a dysfunction of systole, diastole or both?
Yip GW; Fung JW; Tan YT; Sanderson JE
J Hum Hypertens; 2009 May; 23(5):295-306. PubMed ID: 19037230
[TBL] [Abstract][Full Text] [Related]
8. [Pathophysiologic role of myocardial hypertrophy, microcirculatory dysfunction and cardiomyocyte apoptosis in aortic stenosis].
Lotrionte M; Galiuto L; Biondi-Zoccai GG; Abbate A
G Ital Cardiol (Rome); 2006 Jul; 7(7):437-44. PubMed ID: 16977783
[TBL] [Abstract][Full Text] [Related]
9. Experimental ventricular pressure overload in young animals induces cardiomyocyte hypertrophy in addition to hyperplasia of contractile and noncontractile elements of the myocardium.
Abduch MC; Assad RS; Aiello VD
J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1573. PubMed ID: 19464493
[No Abstract] [Full Text] [Related]
10. Effects of percutaneous transluminal septal myocardial ablation for obstructive hypertrophic cardiomyopathy on systolic and diastolic left ventricular function assessed by pressure-volume loops.
Meliga E; Steendijk P; Valgimigli M; Ten Cate FJ; Serruys PW
Am J Cardiol; 2008 Apr; 101(8):1179-84. PubMed ID: 18394455
[TBL] [Abstract][Full Text] [Related]
11. The role of Fas in the progression of ischemic heart failure: prohypertrophy or proapoptosis.
Feng QZ; Zhao YS; Abdelwahid E
Coron Artery Dis; 2008 Nov; 19(7):527-34. PubMed ID: 18923250
[TBL] [Abstract][Full Text] [Related]
12. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
13. Interaction between two predictors of functional outcome after revascularization in ischemic cardiomyopathy: left ventricular volume and amount of viable myocardium.
Mandegar MH; Yousefnia MA; Roshanali F; Rayatzadeh H; Alaeddini F
J Thorac Cardiovasc Surg; 2008 Oct; 136(4):930-6. PubMed ID: 18954632
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and predictors of in-hospital mortality of patients with heart failure with preserved left ventricular ejection fraction.
Pérez de Isla L; Zamorano J; Hernández N; Contreras L; Rodrigo JL; Almería C; Aubele AL; Mataix L; Macaya C
J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1011-5. PubMed ID: 18799963
[TBL] [Abstract][Full Text] [Related]
15. [Effect of tashinone on nitric oxide synthase in hypertrophic cardiomyocyte of rats suffered abdominal aorta constriction].
Li YS; Wang ZH; Yan L; Yong YQ; Wang J; Liang QS; Zheng Z; Yang GT
Zhongguo Zhong Yao Za Zhi; 2008 Jun; 33(12):1446-50. PubMed ID: 18837353
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic changes before acute heart failure episodes in patients with advanced systolic left ventricular dysfunction.
Ghio S; Serio A; Mangiavacchi M; Kjellström B; Valsecchi S; Vicini I; Campana C; Gasparini M; Gronda E; Tavazzi L
J Cardiovasc Med (Hagerstown); 2008 Aug; 9(8):799-804. PubMed ID: 18607244
[TBL] [Abstract][Full Text] [Related]
17. Prevention of hypertrophic cardiomyopathy-related deaths: theory and practice.
Elliott P; Spirito P
Heart; 2008 Oct; 94(10):1269-75. PubMed ID: 18653582
[TBL] [Abstract][Full Text] [Related]
18. [Cellular aspects of hypertrophic cardiomyopathy pathogenesis: the role of cardiomyocyte polyploidy and activation of the proliferating cell nuclear antigen in the myocardium].
Shliakhto EV; Bokeriia LA; Rybakova MG; Semernin EN; Selivanova GV; Vlasova TD; Borisov KV; Parfenov VN; Gudkova AIa
Tsitologiia; 2007; 49(10):817-23. PubMed ID: 18074770
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular hypertrophy, apoptosis, and progression to heart failure in severe aortic stenosis.
Anselmi A; Lotrionte M; Biondi-Zoccai GG; Galiuto L; Abbate A
Eur Heart J; 2005 Dec; 26(24):2747. PubMed ID: 16246825
[No Abstract] [Full Text] [Related]
20. ACE inhibition promotes upregulation of endothelial progenitor cells and neoangiogenesis in cardiac pressure overload.
Müller P; Kazakov A; Jagoda P; Semenov A; Böhm M; Laufs U
Cardiovasc Res; 2009 Jul; 83(1):106-14. PubMed ID: 19380417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
